Deutsche Bank analyst Pito Chickering upgraded DaVita (DVA) to Buy from Hold with a price target of $220, up from $126, following the Q1 report. The firm sees “two shining stars” in the quarter: revenue per treatment and treatment growth. “Currents” are moving into DaVita’s favor, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DVA: